Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT05870969 Sponsor: Ruijin Hospital Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT05870969
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing to take part voluntarily, have been fully informed about the study, and are able to follow all trial procedures
  • People aged between 18 and 75 years old (including those exact ages)
  • People who have had a positive hepatitis B surface antigen (a marker of hepatitis B infection) for 6 months or more
  • People who have been diagnosed with hepatitis C
  • People who have been diagnosed with cirrhosis (scarring of the liver), confirmed by at least one of the following: a liver biopsy showing significant scarring; a liver stiffness scan result above certain thresholds; an abdominal scan showing signs of cirrhosis; or specific blood test scores (APRI or FIB-4) above set levels (confirm with trial site for exact values)
  • People diagnosed with a liver condition related to metabolic problems (called MAFLD), where liver scarring has reached a certain level of severity as measured by a specialised liver scan, combined with more than 5% fat in the liver and either overweight/obesity, type 2 diabetes, or other metabolic issues
  • People diagnosed with MAFLD who also have abnormal blood sugar levels, including type 2 diabetes, prediabetes, or blood sugar or haemoglobin A1c readings within specific ranges (confirm with trial site for exact values)
  • People who have a parent, sibling, or child who has been diagnosed with liver cancer

Who may not be able to join:

  • People younger than 18 or older than 75 years of age
  • People who have already been diagnosed with liver cancer before enrolling
  • People with a severe mental illness or significant cognitive impairment
  • People who are pregnant, breastfeeding, or planning to become pregnant
  • People who have taken part in another clinical trial within the 3 months before this study begins, or who are currently in another clinical trial
  • People whose treating doctor believes they are unlikely to be suitable, for reasons such as difficulty understanding the study requirements, concerns about ability to follow the study plan, poor general health, or any other factors the doctor considers relevant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0086-021-64370045

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
1 March 2023
Est. completion
1 March 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Early diagnosis rate of HCC patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov